Background: Data on burden of peripheral artery disease (PAD) and its attributable risk
factors are valuable for policymaking. We aimed to estimate the burden and risk factors for …

Aims We assessed the impact of the proprotein convertase subtilisin–kexin type 9 (PCSK9)
inhibitor evolocumab on acute arterial events across all vascular territories, including …

Over the past decade, improvements in medical treatment and revascularization techniques
have been beneficial for patients with peripheral artery disease in the late stage of critical …

Background/Objectives: Peripheral arterial disease is a frequent and severe disease with
high cardiovascular morbidity and mortality. However, female patients appear to be …

Background and aims Abdominal aortic calcification (AAC) and low ankle-brachial index
(ABI) are markers of multisite atherosclerosis. We sought to estimate their associations in …

Objective Peripheral arterial disease (PAD) is a manifestation of atherosclerosis that affects
the lower extremities and afflicts more than 200 million people worldwide. Because of limited …

Background Worldwide, peripheral arterial disease (PAD) is a disorder with high morbidity,
affecting more than 200 million people. Objectives Our objective was to analyze surgical …

Background: Characterisation of arterial Doppler waveforms is a persistent problem and a
source of confusion in clinical practice. Classifications have been proposed to address the …

Objective The VOYAGER-PAD trial demonstrated the interest in dual pathway inhibition
(DPI)(low dose rivaroxaban plus aspirin) to reduce limb and cardiovascular events after …

Objective Inpatient treatment of peripheral artery disease (PAD) is more than six times as
costly as that of the general inpatient population. Our objective was to describe factors …